Delivery Order SPE2DB22D3401-SPE2DB25FT5QE
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $27,094.95 and an ultimate completion date of August 8, 2025. This is a non-set-aside, competitively awarded delivery order utilizing an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $27,094.95 by the Defense Logistics Agency on August 14, 2025, for the supply of Voranigo 40 mg tablets (30-count units). This non-set-aside competitive award is scheduled for completion by September 5, 2025, with performance taking place at the company's Conshohocken facility. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Voranigo 40 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $81,284.85 and an ultimate completion date of August 29, 2025. The contract is not set-aside and represents a competitive award to the prime contractor. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,343.83 firm fixed-price contract is for the delivery of VORANIGO 40 MG TABLET 30S, a pharmaceutical product, with a performance period through December 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $27,094.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of 4,568,061,524 units of Voranigo 40 mg tablets, with a completion date of May 19, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, with no...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $27,094.95 firm fixed-price contract is for the delivery of VORANIGO 40 MG TABLET 30S, a pharmaceutical product, with a completion date of July 23, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $27,094.95, is for the delivery of VORANIGO 40 MG TABLET 30S. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 24, 2025. The contract is not designated as a set-aside and was awarded under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999. This IDC serves as a primary...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,385.52 by the Defense Logistics Agency (DLA) on July 25, 2025, with an ultimate completion date of August 15, 2025. The contract, issued under firm fixed-price terms with no set-aside designation, covers the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This delivery order represents a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count unit of use packaging) with a firm fixed price and an ultimate completion date of August 11, 2025. This non-set-aside, competitively awarded delivery order represents a pharmaceutical supply transaction to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $54,211.14 to AmerisourceBergen Drug Corp on August 4, 2025, with completion targeted for August 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT5QEDelivery Order
The Defense Logistics Agency awarded a $27,094.95 delivery order to AmerisourceBergen Drug Corp for Voranigo 40 mg tablets (30-count units) on August 11, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price, non-set-aside contract is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical supplies to support military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has demonstrated its capability to meet federal procurement requirements through competitive award processes. The company's extensive portfolio includes diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. This delivery order for Voranigo exemplifies the company's role as a critical vendor for federal medical procurement, particularly for Defense Health Agency and military healthcare systems, and reflects the company's versatility in fulfilling varying federal medical supply needs ranging from small-value transactions to substantial orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.1k | 8/11/25 |